Literature DB >> 26285140

Overactivation of the nuclear factor (erythroid-derived 2)-like 2-antioxidant response element pathway in hepatocytes decreases hepatic ischemia/reperfusion injury in mice.

Lung-Yi Lee1, Calvin Harberg1, Kristina A Matkowskyj2,3, Shelly Cook2, Drew Roenneburg1, Sabine Werner4, Jeffrey Johnson5,6,7,8, David P Foley1,9.   

Abstract

Hepatic ischemia/reperfusion injury (IRI) is a critical component of hepatic surgery. Oxidative stress has long been implicated as a key player in IRI. In this study, we examine the cell-specific role of the nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-antioxidant response element pathway in warm hepatic IRI. Nrf2 knockout (KO) and wild-type (WT) animals and novel transgenic mice expressing a constitutively active nuclear factor (erythroid-derived 2)-like 2 (caNrf2) mutant in hepatocytes (AlbCre+/caNrf2+) and their littermate controls underwent partial hepatic ischemia or sham surgery. The animals were killed 6 hours after reperfusion, and their serum and tissue were collected for analysis. As compared to WT animals after ischemia/reperfusion (IR), Nrf2 KO mice had increased hepatocellular injury with increased serum alanine aminotransferase and aspartate aminotransferase, Suzuki score, apoptosis, an increased inflammatory infiltrate, and enhanced inflammatory cytokine expression. On the other hand, AlbCre+/caNrf2+ that underwent IR had significantly reduced serum transaminases, less necrosis on histology, and a less pronounced inflammatory infiltrate and inflammatory cytokine expression as compared to the littermate controls. However, there were no differences in apoptosis. Taken together, Nrf2 plays a critical role in our murine model of warm hepatic IRI, with Nrf2 deficiency exacerbating hepatic IRI and hepatocyte-specific Nrf2 overactivation providing protection against warm hepatic IRI.
© 2015 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26285140      PMCID: PMC4718744          DOI: 10.1002/lt.24303

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  33 in total

1.  Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.

Authors:  Yu-Kun Jennifer Zhang; Ronnie L Yeager; Yuji Tanaka; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2010-03-27       Impact factor: 4.219

2.  Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.

Authors:  Kim M Olthoff; Laura Kulik; Benjamin Samstein; Mary Kaminski; Michael Abecassis; Jean Emond; Abraham Shaked; Jason D Christie
Journal:  Liver Transpl       Date:  2010-08       Impact factor: 5.799

Review 3.  Toward clinical application of the Keap1-Nrf2 pathway.

Authors:  Takafumi Suzuki; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Trends Pharmacol Sci       Date:  2013-05-09       Impact factor: 14.819

4.  4-hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway.

Authors:  Yan Zhang; Motoaki Sano; Ken Shinmura; Kayoko Tamaki; Yoshinori Katsumata; Tomohiro Matsuhashi; Shintaro Morizane; Hideyuki Ito; Takako Hishiki; Jin Endo; Heping Zhou; Shinsuke Yuasa; Ruri Kaneda; Makoto Suematsu; Keiichi Fukuda
Journal:  J Mol Cell Cardiol       Date:  2010-06-04       Impact factor: 5.000

Review 5.  Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts.

Authors:  Hartmut Jaeschke
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

Review 6.  Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species.

Authors:  Hartmut Jaeschke; Benjamin L Woolbright
Journal:  Transplant Rev (Orlando)       Date:  2012-04       Impact factor: 3.943

7.  Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-null mice.

Authors:  Lauren M Aleksunes; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2012-04-11       Impact factor: 3.922

8.  Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.

Authors:  Javier Briceño; Ruben Ciria; María Pleguezuelo; Manuel de la Mata; Jordi Muntané; Alvaro Naranjo; Juan Sánchez-Hidalgo; Trinidad Marchal; Sebastián Rufián; Pedro López-Cillero
Journal:  Liver Transpl       Date:  2009-01       Impact factor: 5.799

9.  Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice.

Authors:  Manchang Liu; Dmitry N Grigoryev; Michael T Crow; Mark Haas; Masayuki Yamamoto; Sekhar P Reddy; Hamid Rabb
Journal:  Kidney Int       Date:  2009-05-13       Impact factor: 10.612

10.  Nrf2 links epidermal barrier function with antioxidant defense.

Authors:  Matthias Schäfer; Hany Farwanah; Ann-Helen Willrodt; Aaron J Huebner; Konrad Sandhoff; Dennis Roop; Daniel Hohl; Wilhelm Bloch; Sabine Werner
Journal:  EMBO Mol Med       Date:  2012-03-02       Impact factor: 12.137

View more
  7 in total

1.  Cell-specific overactivation of nuclear erythroid 2 p45-related factor 2-mediated gene expression in myeloid cells decreases hepatic ischemia/reperfusion injury.

Authors:  Lung-Yi Lee; Calvin Harberg; Kristina A Matkowskyj; Shelly Cook; Drew Roenneburg; Sabine Werner; Delinda A Johnson; Jeffrey A Johnson; David P Foley
Journal:  Liver Transpl       Date:  2016-08       Impact factor: 5.799

Review 2.  Relationship between oxidative stress and nuclear factor-erythroid-2-related factor 2 signaling in diabetic cardiomyopathy (Review).

Authors:  Xia Wu; Leitao Huang; Jichun Liu
Journal:  Exp Ther Med       Date:  2021-04-25       Impact factor: 2.447

3.  Hypothermic machine perfusion attenuates ischemia/reperfusion injury against rat livers donated after cardiac death by activating the Keap1/Nrf2‑ARE signaling pathway.

Authors:  Shuai Xue; Weiyang He; Xianpeng Zeng; Zimei Tang; Shoucheng Feng; Zibiao Zhong; Yan Xiong; Yanfeng Wang; Qifa Ye
Journal:  Mol Med Rep       Date:  2018-05-23       Impact factor: 2.952

4.  Immune-Responsive Gene 1/Itaconate Activates Nuclear Factor Erythroid 2-Related Factor 2 in Hepatocytes to Protect Against Liver Ischemia-Reperfusion Injury.

Authors:  Zhongjie Yi; Meihong Deng; Melanie J Scott; Guang Fu; Patricia A Loughran; Zhao Lei; Shilai Li; Ping Sun; Chenxuan Yang; Wenbo Li; Hongbo Xu; Feizhou Huang; Timothy R Billiar
Journal:  Hepatology       Date:  2020-10-12       Impact factor: 17.425

Review 5.  The Antioxidant Transcription Factor Nrf2 in Cardiac Ischemia-Reperfusion Injury.

Authors:  Ana Mata; Susana Cadenas
Journal:  Int J Mol Sci       Date:  2021-11-03       Impact factor: 5.923

6.  Brg1-mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia-reperfusion injury.

Authors:  Mian Ge; Weifeng Yao; Dongdong Yuan; Shaoli Zhou; Xi Chen; Yihan Zhang; Haobo Li; Zhengyuan Xia; Ziqing Hei
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

7.  Maresin 1, a Proresolving Lipid Mediator, Ameliorates Liver Ischemia-Reperfusion Injury and Stimulates Hepatocyte Proliferation in Sprague-Dawley Rats.

Authors:  Gonzalo Soto; María José Rodríguez; Roberto Fuentealba; Adriana V Treuer; Iván Castillo; Daniel R González; Jessica Zúñiga-Hernández
Journal:  Int J Mol Sci       Date:  2020-01-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.